Clostridium difficile Infection

Research output: Contribution to journalReview article

Abstract

Clostridium difficile infection is a major health care challenge in terms of patient and economic consequences. For the patient, it is a morbid and sometimes a life-threatening iatrogenic complication of antibiotic treatment. In the United States, the provider's institution may face financial penalties, because the Centers for Disease Control and Prevention views this as an iatrogenic health care–associated complication that may not be reimbursable by the Centers for Medicare and Medicaid Services; this has resulted in substantial incentives for new approaches to prevention and treatment.

Original languageEnglish (US)
Pages (from-to)489-495
Number of pages7
JournalInfectious Disease Clinics of North America
Volume31
Issue number3
DOIs
StatePublished - Sep 1 2017

Keywords

  • Centers for Disease Control and Prevention
  • Clostridium difficile
  • Intensive care units
  • White blood cell

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Clostridium difficile Infection'. Together they form a unique fingerprint.

  • Cite this